The EVERBIO II ( Comparison of Everolimus - and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents II ) trial was a single-center , assessor-blinded study of @ patients randomly assigned in a @:@:@ ratio to EES , BES , or BVS .